Get started
Author

Yanmei Lu

ORCID: 0000-0002-2772-5154
Observed ORCID: 0000-0002-2772-5154
OpenAlex ID: A5121953334
2025 White Paper on Recent Issues in Bioanalysis: Redosing Patients with AAV Gene Therapy; CRS Immunogenicity Risk; Shedding Assays; NHP Studies Immunogenicity; CMC vs Bioanalytical Assays; Artificial Intelligence-Powered Genomic Pipelines for NGS ( PART 3A – Recommendations on Gene, Cell, and Vaccine Therapies Immunogenicity & Technologies; Biotherapeutics & Biosimilars Immunogenicity Assessment & Clinical Relevance PART 3B – Regulatory Agencies’ Input on Immunogenicity/Technologies of Biotherapeutics, Gene, Cell & Vaccine Therapies)
2025 · Omar Tounekti, Sophie Shubow, et al. · Bioanalysis · 6
PDF
Engineered zinc finger repressors induce a prolonged and selective repression of SCN9A in nociceptors of nonhuman primates
2026 · Mohammad Samie, Toufan Parman, et al. · Science Translational Medicine · 5
Assessment of Immune Responses Against AAV Encoded Transgene Products
2026 · Boris Gorovits, Mitra Azadeh, et al. · The AAPS Journal · 5
Perspectives on PCR-Based Cellular Kinetics and Biodistribution Analysis for Emerging Adoptive Cell Therapies
2026 · Nanda Balasubramanian, Shyam Kumar Gudey, et al. · The AAPS Journal · 2
PDF
Isaralgagene civaparvovec (ST-920) gene therapy for adults with Fabry disease: Pharmacology and immunogenicity outcomes from the phase 1/2 STAAR study and ongoing long-term follow-up
2026 · Yanmei Lu, Liching Cao, et al. · Molecular Genetics and Metabolism
Works count: 5
Citation count: 18
H-index: 3
I10-index:
Year
Topic
Type